These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28392694)

  • 1. A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment.
    Lee JJ; Saiful Yazan L; Che Abdullah CA
    Int J Nanomedicine; 2017; 12():2373-2384. PubMed ID: 28392694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies.
    Cui G; Wu J; Lin J; Liu W; Chen P; Yu M; Zhou D; Yao G
    J Nanobiotechnology; 2021 Jul; 19(1):211. PubMed ID: 34266419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.
    Gote V; Nookala AR; Bolla PK; Pal D
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted nanomaterials for radiotherapy.
    Escorcia FE; McDevitt MR; Villa CH; Scheinberg DA
    Nanomedicine (Lond); 2007 Dec; 2(6):805-15. PubMed ID: 18095847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
    Raj R; Mongia P; Kumar Sahu S; Ram A
    Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy.
    Ashrafizadeh M; Zarrabi A; Bigham A; Taheriazam A; Saghari Y; Mirzaei S; Hashemi M; Hushmandi K; Karimi-Maleh H; Nazarzadeh Zare E; Sharifi E; Ertas YN; Rabiee N; Sethi G; Shen M
    Med Res Rev; 2023 Nov; 43(6):2115-2176. PubMed ID: 37165896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine and its applications to the treatment of prostate cancer.
    Ouvinha de Oliveira R; de Santa Maria LC; Barratt G
    Ann Pharm Fr; 2014 Sep; 72(5):303-16. PubMed ID: 25220226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
    Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-based materials in anticancer drug delivery: Current and future prospects.
    Ajith S; Almomani F; Elhissi A; Husseini GA
    Heliyon; 2023 Nov; 9(11):e21227. PubMed ID: 37954330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine in treatment of breast cancer - A challenge to conventional therapy.
    Afzal M; Ameeduzzafar ; Alharbi KS; Alruwaili NK; Al-Abassi FA; Al-Malki AAL; Kazmi I; Kumar V; Kamal MA; Nadeem MS; Aslam M; Anwar F
    Semin Cancer Biol; 2021 Feb; 69():279-292. PubMed ID: 31870940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
    Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
    Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-based nanocarriers for breast cancer treatment - comprehensive review.
    Talluri SV; Kuppusamy G; Karri VV; Tummala S; Madhunapantula SV
    Drug Deliv; 2016 May; 23(4):1291-305. PubMed ID: 26430913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine applications in the treatment of breast cancer: current state of the art.
    Wu D; Si M; Xue HY; Wong HL
    Int J Nanomedicine; 2017; 12():5879-5892. PubMed ID: 28860754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.